AIDS Biology

Edited by: Ricki Lewis IMPACT ON TREATMENT: John Mellors remarks that his papers "go a long way towards a more accurate assessment" of prognosis in people with AIDS. J.W. Mellors, L.A. Kingsley, C.R. Rinaldo, Jr., J.A. Todd, B.S. Hoo, R.P. Kokka, P. Gupta, "Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion," Annals of Internal Medicine, 122:573-9, 1995. (Cited in more than 150 publications through June 1997) J.W. Mellors, C.R. Rinaldo, Jr., P. Gupta, R.M. White, J.A. T

| 3 min read

Save for Later

Listen with Speechify

0:00

3:00

Edited by: Ricki Lewis

IMPACT ON TREATMENT: John Mellors remarks that his papers "go a long way towards a more accurate assessment" of prognosis in people with AIDS.

J.W. Mellors, L.A. Kingsley, C.R. Rinaldo, Jr., J.A. Todd, B.S. Hoo, R.P. Kokka, P. Gupta, "Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion," Annals of Internal Medicine, 122:573-9, 1995. (Cited in more than 150 publications through June 1997)

J.W. Mellors, C.R. Rinaldo, Jr., P. Gupta, R.M. White, J.A. Todd, L.A. Kingsley, "Prognosis in HIV-1 infection predicted by the quantity of virus in plasma," Science, 272:1167-70, 1996. (Cited in more than 100 publications through June 1997)

Comments by John W. Mellors, University of Pittsburgh Medical Center.

Tracking progression of AIDS has evolved from observing symptoms to detecting antibodies against HIV to counting helper T cells to monitoring viral load. A team led by John W. Mellors, an associate professor of medicine ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here